Farallon Capital Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
|
|||||
|
2024
Q4 | $180M | Buy |
|
|||||
|
2021
Q1 | – | Sell |
|
|||||
|
2020
Q4 | $15.5M | Sell |
|
|||||
|
2020
Q3 | $226M | Buy |
|
|||||
|
2020
Q2 | $213M | Buy |
|
|||||
|
2018
Q1 | – | Sell |
|
|||||
|
2017
Q4 | $73.1M | Sell |
|
|||||
|
2017
Q3 | $86.4M | Buy |
|
|||||
|
2017
Q2 | – | Sell |
|
|||||
|
2017
Q1 | $24.1M | Buy |
|
|||||
|
2016
Q4 | $18.1M | Buy |
|